Colchicine for secondary prevention of ischaemic stroke and atherosclerotic events: a meta-analysis of randomised trials

Guidelines recommend low-dose colchicine for secondary prevention in cardiovascular disease, but uncertainty remains concerning its efficacy for stroke, efficacy in key subgroups and about uncommon but serious safety outcomes. In this trial-level meta-analysis, we searched bibliographic databases an...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	EClinicalMedicine 2024-10, Vol.76, p.102835, Article 102835
Hauptverfasser:	Fiolet, Aernoud T.L., Poorthuis, Michiel H.F., Opstal, Tjerk S.J., Amarenco, Pierre, Boczar, Kevin Emery, Buysschaert, Ian, Budgeon, Charley, Chan, Noel C., Cornel, Jan H., Jolly, Sanjit S., Layland, Jamie, Lemmens, Robin, Mewton, Nathan, Nidorf, Stefan M., Pascual-Figal, Domingo A., Price, Christopher, Shah, Binita, Tardif, Jean-Claude, Thompson, Peter L., Tijssen, Jan G.P., Tsivgoulis, Georgios, Walsh, Cathal, Wang, Yongjun, Weimar, Christian, Eikelboom, John W., Mosterd, Arend, Kelly, Peter J.
Format:	Artikel
Sprache:	eng
Schlagworte:	Colchicine MACE Meta-analysis Safety Stroke
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!